Veracyte reported $1.13B in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Agenus AGEN:US USD 429.02M 27.15M
Agilent A:US USD 10.53B 48M
Anika Therapeutics ANIK:US USD 347.75M 6.38M
Arrowhead Research ARWR:US USD 691.94M 59.84M
Biocept BIOC:US USD 51.1M 7.04M
Bruker BRKR:US USD 3.34B 47.9M
Exact Sciences EXAS:US USD 6.31B 130.59M
Heron Therapeutics HRTX:US USD 271.95M 27.99M
Illumina ILMN:US USD 11.26B 4.19B
Immunogen IMGN:US USD 358.8M 63.5M
Intrexon XON:US USD 259.24M 61.98M
Karyopharm Therapeutics KPTI:US USD 231.24M 25.24M
Laboratory Of America LH:US USD 19.83B 577.1M
Ligand Pharmaceuticals LGND:US USD 1.05B 25.68M
Myriad Genetics MYGN:US USD 1.21B 1.8M
Roche Holding ROG:VX 86.74B 5.58B
Sangamo Biosciences SGMO:US USD 593.91M 23.21M
Siemens SIE:GR EUR 151.5B 5.51B
Sonic Healthcare SHL:AU AUD 12.55B 87.82M
Thermo Fisher Scientific TMO:US USD 90.54B 43M
Veracyte VCYT:US USD 1.13B 18.24M
Waters WAT:US USD 3.07B 29.48M